Waymond D. Bray

Array ( [id] => 5534483 [patent_doc_number] => 20090234271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-17 [patent_title] => 'COMPOSITION COMPRISING siRNA-POLYCATION COMPLEX FOR IONTOPHORESIS' [patent_app_type] => utility [patent_app_number] => 12/392883 [patent_app_country] => US [patent_app_date] => 2009-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8884 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20090234271.pdf [firstpage_image] =>[orig_patent_app_number] => 12392883 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509096 [patent_doc_number] => 20090082303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'DRUG FOR PREVENTING AND TREATING ATHEROSCLEROSIS' [patent_app_type] => utility [patent_app_number] => 12/274736 [patent_app_country] => US [patent_app_date] => 2008-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28457 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082303.pdf [firstpage_image] =>[orig_patent_app_number] => 12274736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5441800 [patent_doc_number] => 20090093439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)' [patent_app_type] => utility [patent_app_number] => 12/205558 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 74925 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20090093439.pdf [firstpage_image] =>[orig_patent_app_number] => 12205558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446885 [patent_doc_number] => 20090048111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'RNA INTERFERENCE USING A UNIVERSAL TARGET' [patent_app_type] => utility [patent_app_number] => 12/205327 [patent_app_country] => US [patent_app_date] => 2008-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 30186 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048111.pdf [firstpage_image] =>[orig_patent_app_number] => 12205327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792688 [patent_doc_number] => 20080293662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'RNAi MODULATION OF THE BCR-ABL FUSION GENE AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/171291 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18103 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293662.pdf [firstpage_image] =>[orig_patent_app_number] => 12171291 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5509348 [patent_doc_number] => 20090082555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-26 [patent_title] => 'Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics' [patent_app_type] => utility [patent_app_number] => 12/157383 [patent_app_country] => US [patent_app_date] => 2008-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 46400 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20090082555.pdf [firstpage_image] =>[orig_patent_app_number] => 12157383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5297099 [patent_doc_number] => 20090012025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Methods and Compositions for Treatment of Sepsis' [patent_app_type] => utility [patent_app_number] => 12/029412 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 15851 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0012/20090012025.pdf [firstpage_image] =>[orig_patent_app_number] => 12029412 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727260 [patent_doc_number] => 20080206803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Metabolic genes and related methods and compositions' [patent_app_type] => utility [patent_app_number] => 12/012781 [patent_app_country] => US [patent_app_date] => 2008-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10530 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206803.pdf [firstpage_image] =>[orig_patent_app_number] => 12012781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337901 [patent_doc_number] => 20090054365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION' [patent_app_type] => utility [patent_app_number] => 12/020923 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13012 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20090054365.pdf [firstpage_image] =>[orig_patent_app_number] => 12020923 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4740567 [patent_doc_number] => 20080234220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Methods and compositions for reducing viral genome amounts in a small target stem cell' [patent_app_type] => utility [patent_app_number] => 11/953705 [patent_app_country] => US [patent_app_date] => 2007-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8826 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20080234220.pdf [firstpage_image] =>[orig_patent_app_number] => 11953705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4728005 [patent_doc_number] => 20080207549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'GENES AND POLYPEPTIDES RELATING TO HEPATOCELLULAR OR COLORECTAL CARCINOMA' [patent_app_type] => utility [patent_app_number] => 11/948790 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 31537 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20080207549.pdf [firstpage_image] =>[orig_patent_app_number] => 11948790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4808141 [patent_doc_number] => 20080171719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 11/946395 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11976 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171719.pdf [firstpage_image] =>[orig_patent_app_number] => 11946395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676855 [patent_doc_number] => 20080214486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS' [patent_app_type] => utility [patent_app_number] => 11/946335 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12089 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20080214486.pdf [firstpage_image] =>[orig_patent_app_number] => 11946335 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954969 [patent_doc_number] => 20080187993 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'METHOD AND ANTISENSE COMPOSITION FOR SELECTIVE INHIBITION OF HIV INFECTION IN HEMATOPOIETIC CELLS' [patent_app_type] => utility [patent_app_number] => 11/940987 [patent_app_country] => US [patent_app_date] => 2007-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12276 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187993.pdf [firstpage_image] =>[orig_patent_app_number] => 11940987 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 217286 [patent_doc_number] => 07612196 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-03 [patent_title] => 'siRNA targeting cyclin-dependent kinase inhibitor 1B (p27, Kip1) (CDKN1B)' [patent_app_type] => utility [patent_app_number] => 11/978900 [patent_app_country] => US [patent_app_date] => 2007-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34300 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/612/07612196.pdf [firstpage_image] =>[orig_patent_app_number] => 11978900 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693231 [patent_doc_number] => 20080086002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'siRNA targeting secreted frizzled-related protein 1 (sFRP1)' [patent_app_type] => utility [patent_app_number] => 11/978125 [patent_app_country] => US [patent_app_date] => 2007-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 34319 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20080086002.pdf [firstpage_image] =>[orig_patent_app_number] => 11978125 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4922756 [patent_doc_number] => 20080071073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-03-20 [patent_title] => 'siRNA targeting ubiquitin ligases' [patent_app_type] => utility [patent_app_number] => 11/977675 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 33922 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20080071073.pdf [firstpage_image] =>[orig_patent_app_number] => 11977675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5392165 [patent_doc_number] => 20090209478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE HAMP GENE' [patent_app_type] => utility [patent_app_number] => 11/859288 [patent_app_country] => US [patent_app_date] => 2007-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16768 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209478.pdf [firstpage_image] =>[orig_patent_app_number] => 11859288 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839385 [patent_doc_number] => 20080279870 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'ALK protein tyrosine kinase, cells and methods embodying and using same' [patent_app_type] => utility [patent_app_number] => 11/901487 [patent_app_country] => US [patent_app_date] => 2007-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23097 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279870.pdf [firstpage_image] =>[orig_patent_app_number] => 11901487 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4693228 [patent_doc_number] => 20080085999 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-10 [patent_title] => 'MODULATION OF GENE EXPRESSION USING DNA-RNA HYBRIDS' [patent_app_type] => utility [patent_app_number] => 11/830647 [patent_app_country] => US [patent_app_date] => 2007-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8883 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0085/20080085999.pdf [firstpage_image] =>[orig_patent_app_number] => 11830647 [rel_patent_id] =>[rel_patent_doc_number] =>)